Treatment of Hypertension in Patients with Polymorbidity: Sartans

Abstract

Diseases of the cardiovascular system is often accompanied by other serious diseases – it called polymorbidity. In such cases it is necessary to carefully select drugs for treatment, paying particular attentiong to their influence on each other in the human organism, efficiency of their simultaneous appointment and safety against side effects. For the treatment of hypertension successfully used angiotensin receptor blockers II, which have proven to be effective antihypertensive drugs with additional therapeutic properties. Among the other members of the group candesartan (Candesar, SUN pharma company) gained recognition among doctors thanks to the good performance of lowering blood pressure, as well as the additional effects, such as: nefroprotection, improvement current diabetes and even prevent further his case, antiatherosclerotic action. Candesartan acts as an effective hypotensive drug, which is also capable of preventing the development of hypertension, in addition shows good results with regard to increasing the duration of life of the patients and improve the prognosis of cardiovascular diseases. The accumulated evidence base and years of experience in the use clinicians confirm efficacy and safety of candesartan in patients with polymorbidity.